Feedback
Settings

Settings

Goto Application

1. US20210079022 - HETEROARYL PLASMA KALLIKREIN INHIBITORS

PermaLink
Office
United States of America
Application Number 17024189
Application Date 17.09.2020
Publication Number 20210079022
Publication Date 18.03.2021
Publication Kind A1
IPC
C07D 519/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
519Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/ or C07D455/257
CPC
C07D 519/00
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
519Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Applicants Shire Human Genetic Therapies, Inc.
Inventors Nikolaos Papaioannou
Jeremy Mark Travins
Sarah Jocelyn Fink
John Mark Ellard
Alastair Rae
Title
(EN) HETEROARYL PLASMA KALLIKREIN INHIBITORS
Abstract
(EN)

The present invention provides compounds and compositions thereof which are useful as inhibitors of plasma kallikrein and which exhibit desirable characteristics for the same.
Related patent documents
WO/2021/055589
EP2020781702This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
# -